Schizophrenia

Grin2a Gene Linked to Mediodorsal Thalamus Activity and Belief Updating in Schizophrenia

by
Mediodorsal Thalamus Activity Restored Belief Updating

Mediodorsal Thalamus Activity Restored Belief Updating TL;DR: A Nature Neuroscience mouse study linked a schizophrenia-risk Grin2a mutation to weaker mediodorsal thalamus activity, impaired belief updating, and behavioral rescue when researchers reactivated the thalamus-prefrontal circuit during flexible decision-making in mice. Key Findings Grin2a was the genetic entry point: The mutation affects an NMDA receptor subunit gene …

Read more

AVATAR Therapy Outperformed CBT at 3 Months for Auditory Hallucinations

by
AVATAR Therapy Outlasted CBT for Auditory Hallucinations

AVATAR Therapy Outlasted CBT for Auditory Hallucinations TL;DR: AVATAR therapy matched CBT on voice severity right after treatment, then pulled ahead at 3 months — with roughly half the sessions. A 26-trial meta-analysis, 2,273 patients. Key Findings No clear edge at treatment end: AVATAR did not significantly beat CBT on voice severity right after therapy …

Read more

First-Episode Psychosis Reduced CSF C4A-C1Q Immune Coupling

by
C4A Broke Away From C1Q in First-Episode Psychosis

C4A Broke Away From C1Q in First-Episode Psychosis TL;DR: In cerebrospinal fluid from people with first-episode psychosis, the usual positive relationship between C4A and C1Q disappeared, while C4A’s broader immune-network pattern shifted sharply in a way C4B did not. Key Findings C4A-C1Q coupling broke in psychosis: The study compared 113 patients with first-episode psychosis against …

Read more

Sleep Patterns vs. Risk of Psychiatric Disorders: Depression, Schizophrenia, ADHD (2024 Study)

by

Insomnia and daytime napping are causally associated with an increased risk of major depressive disorder (MDD), while sleep duration influences the risk of schizophrenia and attention-deficit/hyperactivity disorder (ADHD). Highlights: Major Depressive Disorder (MDD): Insomnia and napping during the day significantly increase the risk of MDD. Schizophrenia: Longer sleep duration is associated with a higher risk …

Read more

Novel Risk Genes for Schizophrenia Discovered in High Altitude Tibetans via Whole-Exome Sequencing (2024 Study)

by

A study on Tibetans living at high altitudes identified novel risk genes for schizophrenia (SCZ) related to hypoxia, suggesting a unique genetic signature for SCZ in this population. Highlights: Whole-exome sequencing of 47 SCZ cases and 53 controls in Tibetans revealed 275 potential novel risk variants and two known variants. One gene, C5orf42, surpassed exome-wide …

Read more

Epigenetic Biosignature of First-Episode Schizophrenia Identified via Machine Learning (2024)

by

A new study uses AutoML and blood DNA methylation data to identify novel gene biomarkers for diagnosing schizophrenia (SCZ) with high accuracy. Highlights: Biomarker Discovery: AutoML identified three schizophrenia-specific gene methylation biomarkers: IGF2BP1, CENPI, and PSME4. Methylation Analysis: IGF2BP1 showed higher methylation and PSME4 showed lower methylation in SCZ patients compared to healthy controls, while …

Read more

BPC-157 Peptide May Treat CNS Disorders: Stroke, Schizophrenia, Spinal Cord Injury

by

The naturally occurring peptide BPC 157 shows potential to treat stroke, schizophrenia symptoms, and spinal cord injury in animal models. Key facts: BPC 157 rapidly counteracted stroke damage and led to full recovery of memory, coordination and movement in rats. The peptide alleviated schizophrenia-like symptoms and catalepsy in rodent models by modulating dopamine, glutamate and …

Read more

Parental Inbreeding (Consanguinity) Increases Risk of Schizophrenia (South India Study)

by

A new study conducted in rural South India has found that people whose parents are blood relatives (consanguineous marriage) have an increased risk of developing schizophrenia compared to the general population. Key Facts: Researchers recruited 120 patients with schizophrenia and 222 healthy controls from the same rural region in South India. 10.7% of patients with …

Read more

Antipsychotics & Gray Matter Loss in Chronic Schizophrenia

by

Schizophrenia is a severe mental illness characterized by hallucinations, delusions, disorganized thinking and behavior. While antipsychotic medications can help manage symptoms, their long-term effects on brain structure are not fully understood. A new study provides important insights into how long-term antipsychotic treatment may impact gray matter in chronic schizophrenia. Key Facts: Both treated and untreated …

Read more

TACS for Schizophrenia: Early Promise of Transcranial Alternating Current Stimulation

by

Schizophrenia is a severe mental disorder affecting about 1% of the population worldwide. It is characterized by hallucinations, delusions, disorganized thinking and behavior, and impaired cognitive functioning. Current treatments with antipsychotic medications are helpful but have significant limitations, especially for cognitive deficits and negative symptoms like social withdrawal and lack of motivation. This has driven …

Read more

+ Load more